
BMG LABTECH is owned and operated by BMG Labtech GmbH, a privately held, family-owned German company headquartered in Ortenberg, Baden-Wurttemberg. Founded in 1989 by physicist Dr. Bela Gurath, the company is led by owner and managing director Thomas Rabiger and has no external investors.
Parent Company
Founded
1989
Status
Private
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| BMG LABTECH | BMG Labtech GmbH | Brand division |
Physicist Dr. Bela Gurath founded the company in Offenburg, Germany, around 1989 and 1990 as a one-man engineering office. The early business designed microplate reading and handling components for other manufacturers before the team decided to build its own instruments. Thomas Rabiger joined as a shareholder in the first years and now leads the company.
The breakthrough came in 1993, when a development grant funded a fluorescence measurement device and the company launched the FLUOstar, only the second fluorescence-based microplate reader on the market. That instrument established the template the company still follows: modular, multi-mode readers built for life-science research.
The product line expanded through the 1990s and 2000s into a family of named platforms. The LUMIstar, NEPHELOstar, and SPECTROstar addressed luminescence, light scattering, and absorbance measurement. The PHERAstar targeted high-throughput drug screening. The CLARIOstar, with its atmospheric control unit and monochromator technology, became the flagship for assay development. The VANTAstar and Omega series filled out the range.
The company moved to its purpose-built headquarters in Ortenberg, in the Ortenau district of Baden-Wurttemberg, and later expanded the site as headcount grew. Subsidiaries opened in the United States, United Kingdom, France, Japan, and Australia, backed by a dealer network of more than 50 firms worldwide. In January 2024 the company acquired and merged BioDataAnalysis GmbH, adding assay software and data analysis capability.
What does BMG Labtech own?
The company owns the BMG LABTECH brand, its Ortenberg manufacturing and headquarters site, five international subsidiaries in the US, UK, France, Japan, and Australia, and the BioDataAnalysis software capability merged into the business in 2024.
Is BMG Labtech publicly traded?
No. BMG Labtech GmbH is a private family-owned company. It has no shares listed on any exchange, no venture capital investors, and no corporate parent.
Who founded BMG Labtech?
Dr. Bela Gurath, a physicist, founded the company in Offenburg, Germany, in 1989. Thomas Rabiger joined as a shareholder in the early years and now leads the company as owner and managing director.
Where is BMG Labtech headquartered?
The company is headquartered at Allmendgrün 8 in Ortenberg, Baden-Wurttemberg, Germany, in the Ortenau district near Offenburg. All instruments are designed, assembled, and tested at this site.
How many brands does BMG Labtech own?
One. BMG LABTECH is the company's only brand, covering all of its microplate reader platforms, software, accessories, and services.
Who owns BMG Labtech?
The company is family-owned. Thomas Rabiger is the principal shareholder and managing director. There are no institutional investors or external shareholders.
What are BMG Labtech's main products?
Its product line is microplate readers: the FLUOstar, PHERAstar, CLARIOstar, SPECTROstar, VANTAstar, and Omega series, covering detection modes from absorbance and luminescence to time-resolved fluorescence and Alpha technology, plus software and accessories.
BMG LABTECH instruments have won recognition within the life-science instrumentation field, including SelectScience's Scientists' Choice Awards for the CLARIOstar Plus in the microplate reader category. The company's instruments are also widely cited in peer-reviewed research, a standard quality signal in the instrumentation industry.
Its strongest independent credential is longevity: more than 35 years focused exclusively on one product category, with a customer base spanning the largest pharmaceutical companies and research universities worldwide.
No direct competitors found in the same category. This could be because BMG LABTECHoperates in a unique market segment or we're still building our competitor database.
Looking for brands with different ownership structures? These similar brands are not owned by BMG Labtech GmbH, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Alcon Inc.
Independent publicly traded global eye care company headquartered in Geneva, Switzerland, specializing in surgical equipment, contact lenses, and ophthalmic products. Spun off from Novartis in April 2019.
Alcon operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Amgen Inc.
Master biotechnology brand of Amgen Inc., the world's largest independent biotech, covering its full portfolio of biologic medicines.
Amgen operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Arthrex Inc.
Orthopedic device brand of privately held Arthrex Inc., specializing in arthroscopic surgery products sold in more than 100 countries.
Arthrex operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by AstraZeneca PLC
British-Swedish pharmaceutical brand behind Tagrisso and Farxiga, owned by publicly traded AstraZeneca PLC formed by merger in 1999.
AstraZeneca operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Boehringer Ingelheim
German family-owned pharmaceutical brand behind Jardiance and Spiriva, founded in 1885 and still controlled by the Boehringer family.
Boehringer Ingelheim operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Brainlab SE
Munich surgical navigation and radiotherapy software brand installed in about 4,000 hospitals worldwide.
Brainlab operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Consumer DNA testing brand now run as a nonprofit under TTAM Research Institute following the 2025 bankruptcy sale of 23andMe Holding Co.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Abbott Laboratories' medical device business spanning cardiovascular, diabetes care (FreeStyle Libre), neuromodulation, and structural heart, generating roughly $20 billion annually.